Akero Therapeutics, Inc. (AKRO) Covered Calls

You can sell covered calls on Akero Therapeutics, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for AKRO (prices last updated Thu 10:00 AM ET):

Akero Therapeutics, Inc. (AKRO) Stock Quote
Last	Change	Bid	Ask	Volume	P/E	Market Cap
27.70	-1.01	27.61	27.81	41K	-	2.0

Covered Calls For Akero Therapeutics, Inc. (AKRO)
Expiration	Strike	Call Bid	Net Debit	Return If Flat	Annualized Return If Flat
Dec 20	27.5	0.00	27.81	-1.1%	-200.8%
Jan 17	27.5	2.15	25.66	7.2%	87.6%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls? Sign Up For A Free Trial

Extended Business Description

Akero Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for serious metabolic diseases. Its lead product candidate is AKR-001, which is in Phase IIa clinical trial for the treatment of nonalcoholic steatohepatitis disease.The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was founded in 2017 and is headquartered in South San Francisco, California.

Top 10 Open Interest For Dec 20 Expiration				Top 5 High Yield
1.	NVDA covered calls	6.	EEM covered calls	1.	NMRA covered calls
2.	SPY covered calls	7.	IWM covered calls	2.	FDX covered calls
3.	XLF covered calls	8.	TLT covered calls	3.	WULF covered calls
4.	QQQ covered calls	9.	TSLA covered calls	4.	SERV covered calls
5.	FXI covered calls	10.	KWEB covered calls	5.	ALT covered calls

Want more examples? AKR Covered Calls | AKTS Covered Calls